Pink Luminous Breast, Breast transilluminator
Published July 17, 2024 · Recall initiated: May 20, 2024
Summary
FDA records medical device Class II recall Z-2269-2024, published July 17, 2024 and initiated May 20, 2024. Recalling firm: Silkprousa LLC; Status: Ongoing; Reported quantity: 2000 devices; Lot: Product is not lot coded, all devices are subject. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Firm is marketing and distributing the Pink Luminous Breast device without premarket approval
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Silkprousa LLC
- Distributor
- US Nationwide distribution in the states of WA, RI.
- Lot
- Product is not lot coded, all devices are subject
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABAUSCH+LOMB, I-PACK Injection Kit with Wire Speculum, REF 18069W, for the administration of intravitrealJuly 17, 2024
- FDA24K Premium Lense, Distributed by Updream Inc.July 17, 2024
- FDABAUSCH+LOMB, I-PACK Injection Kit Custom, REF 18069, for the administration of intravitreal injection (eye)July 17, 2024
- FDAALPHAMAXX Mobile Operating Table, Model Number/Part Number: 113322B4July 17, 2024
- FDABAUSCH+LOMB, I-PACK Injection Kit with Drape, REF 18061, for the administration of intravitreal injectionJuly 17, 2024
- FDAALPHAMAXX Mobile Operating Table, Model Number/Part Number: 113322B5July 17, 2024
Questions about this recall
Was Pink Luminous Breast, Breast transilluminator recalled?
Yes. FDA published recall Z-2269-2024 on July 17, 2024. Reported hazard: Firm is marketing and distributing the Pink Luminous Breast device without premarket approval
What should I do if I have this product?
Voluntary: Firm initiated · Letter